Proteomics analysis in lung cancer: challenges and opportunities.
Recent technological developments in proteomic analysis are bringing us new insights into the molecular classification of tumours. Although proteomic analysis in cancer profiling is still under development both in terms of the instruments used and the data analytical tools, this method has great potential advantages for the analysis of biospecimens of many types. Direct measurement of abnormally expressed or modified proteins in the tumour tissue and/or patient blood may be an effective approach for discovering new biomarkers. Proteomics has the significant advantage of being able to discern not only changes in expression levels but also in post-translational modifications. Thus, the proteomics approach to protein profiling and biomarker discovery uncovers biomarkers from a different viewpoint than microarray analysis. This review summarizes the range of proteomics technologies employed for cancer profiling, and how they have been used to derive new classification models for human lung cancer.
Kikuchi
Takefumi
T
Vanderbilt Ingram Cancer Center, Nashville, Tennessee 37232, USA.
Carbone
David P
DP
D014408:Biomarkers, Tumor / Q000032:analysis*; D006801:Humans; D008175:Lung Neoplasms / Q000145:classification / Q000378:metabolism*; D040901:Proteomics / Q000379:methods* / Q000639:trends*
D014408:Biomarkers, Tumor